Karin E de Visser (Karin de Visser)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Metastatic Breast Cancer

Regulatory T Cells

Sentinel Lymph Node

Top Venues

Nature reviews. Cancer

Nature communications

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Iris Nederlof, Olga I Isaeva, Manon de Graaf, Robbert C A M Gielen, Noor A M Bakker, Adrianne L Rolfes, Hannah Garner, Bram Boeckx, Joleen J H Traets, Ingrid A M Mandjes, Michiel de Maaker, Thomas van Brussel, Maksim A Chelushkin, Elisa Champanhet, Marta Lopez-Yurda, Koen K van de Vijver, José G van den Berg, Ingrid Hofland, Natasja Klioueva, Ritse M Mann, Claudette E Loo, Frederieke H van Duijnhoven, Victoria Skinner, Sylvia Luykx, Emile Kerver, Ekaterina Kalashnikova, Marloes G J van Dongen, Gabe S Sonke, Sabine C Linn, Christian U Blank, Karin E de Visser, Roberto Salgado, Lodewyk F A Wessels, Caroline A Drukker, Ton N M Schumacher, Hugo Mark Horlings, Diether Lambrechts, Marleen Kok
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial. Nature medicine (2024)
Olga S Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I Isaeva, Hannah Garner, Max D Wellenstein, Noor Bakker, Danique E M Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A M Raeven, Kim Vrijland, Marleen Kok, Karin E de Visser
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology 12 (1) (2023)
Leonie Voorwerk, Olga I Isaeva, Hugo Mark Horlings, Sara Balduzzi, Maksim Chelushkin, Noor A M Bakker, Elisa Champanhet, Hannah Garner, Karolina Sikorska, Claudette E Loo, Inge Kemper, Ingrid A M Mandjes, Michiel de Maaker, Jasper J L van Geel, Jorianne Boers, Maaike de Boer, Roberto Salgado, Marloes G J van Dongen, Gabe S Sonke, Karin E de Visser, Ton N M Schumacher, Christian U Blank, Lodewyk F A Wessels, Agnes Jager, Vivianne C G Tjan-Heijnen, Carolien P Schröder, Sabine C Linn, Marleen Kok
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial. Nature cancer (2023)
Olga S Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I Isaeva, Hannah Garner, Max D Wellenstein, Noor Bakker, Danique E M Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A M Raeven, Kim Vrijland, Marleen Kok, Karin E de Visser
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology 12 (1) (2023)
Antoinette van Weverwijk, Karin E de Visser
Mechanisms driving the immunoregulatory function of cancer cells. Nature reviews. Cancer (2023)
Antoinette van Weverwijk, Karin E de Visser
Mechanisms driving the immunoregulatory function of cancer cells. Nature reviews. Cancer (2023)
Olga S Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I Isaeva, Hannah Garner, Max D Wellenstein, Noor Bakker, Danique E M Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A M Raeven, Kim Vrijland, Marleen Kok, Karin E de Visser
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology 12 (1) (2023)
Antoinette van Weverwijk, Karin E de Visser
Mechanisms driving the immunoregulatory function of cancer cells. Nature reviews. Cancer (2023)
Olga S Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I Isaeva, Hannah Garner, Max D Wellenstein, Noor Bakker, Danique E M Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A M Raeven, Kim Vrijland, Marleen Kok, Karin E de Visser
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology 12 (1) (2023)
Hanne Lefrère, Kat S Moore, Giuseppe Floris, Joyce Sanders, Iris M Seignette, Tycho Bismeijer, Dennis Peters, Annegien Broeks, Erik Hooijberg, Kristel Van Calsteren, Patrick Neven, Ellen Warner, Fedro Alessandro Peccatori, Sibylle Loibl, Charlotte Maggen, Sileny N Han, Katarzyna Joanna Jerzak, Daniela Annibali, Diether Lambrechts, Karin E de Visser, Lodewyk F A Wessels, Liesbeth Lenaerts, Frédéric Amant
Poor outcome in postpartum breast cancer patients is associated with distinct molecular and immunological features. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Olga S Blomberg, Kevin Kos, Lorenzo Spagnuolo, Olga I Isaeva, Hannah Garner, Max D Wellenstein, Noor Bakker, Danique E M Duits, Kelly Kersten, Sjoerd Klarenbeek, Cheei-Sing Hau, Daphne Kaldenbach, Elisabeth A M Raeven, Kim Vrijland, Marleen Kok, Karin E de Visser
Neoadjuvant immune checkpoint blockade triggers persistent and systemic T reg activation which blunts therapeutic efficacy against metastatic spread of breast tumors. Oncoimmunology 12 (1) (2023)
Kevin Kos, Camilla Salvagno, Max D Wellenstein, Muhammad A Aslam, Denize A Meijer, Cheei-Sing Hau, Kim Vrijland, Daphne Kaldenbach, Elisabeth A M Raeven, Martina Schmittnaegel, Carola H Ries, Karin E de Visser
Tumor-associated macrophages promote intratumoral conversion of conventional CD4 + T cells into regulatory T cells via PD-1 signalling. Oncoimmunology 11 (1) (2022)
Wietske Pieters, Floor Hugenholtz, Kevin Kos, Maxime Cammeraat, Teddy C Moliej, Daphne Kaldenbach, Sjoerd Klarenbeek, Mark Davids, Lisa Drost, Charlotte de Konink, Elly Delzenne-Goette, Karin E de Visser, Hein Te Riele
Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model. Gut microbes 14 (1) (2022)
Dario Zimmerli, Chiara S Brambillasca, Francien Talens, Jinhyuk Bhin, Renske Linstra, Lou Romanens, Arkajyoti Bhattacharya, Stacey E P Joosten, Ana Moises Da Silva, Nuno Padrao, Max D Wellenstein, Kelly Kersten, Mart de Boo, Maurits Roorda, Linda Henneman, Roebi de Bruijn, Stefano Annunziato, Eline van der Burg, Anne Paulien Drenth, Catrin Lutz, Theresa Endres, Marieke van de Ven, Martin Eilers, Lodewyk F A Wessels, Karin E de Visser, Wilbert Zwart, Rudolf S N Fehrmann, Marcel A T M van Vugt, Jos Jonkers
MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling. Nature communications 13 (1) (2022)
Abdel Razaq Ahmad A Alyasin, Borko Amulic, Monowar Aziz, Betsy J Barnes, Evgeniy B Eruslanov, Zvi G Fridlender, Helen S Goodridge, Zvi Granot, Andrés Hidalgo, Anna Huttenlocher, Mariana J Kaplan, Ilaria Malanchi, Taha Merghoub, Etienne Meylan, Vivek Mittal, Mikaël J Pittet, Andrea Rubio-Ponce, Irina A Udalova, Timo K van den Berg, Denisa D Wagner, Ping Wang, Arturo Zychlinsky, Karin E de Visser, Mikala Egeblad, Paul Kubes
Neutrophil phenotypes and functions in cancer: A consensus statement. The Journal of experimental medicine 219 (6) (2022)
Danique E M Duits, Camilla Salvagno, Elisabeth A M Raeven, Kim Vrijland, Marjolein C Stip, Cheei-Sing Hau, Daphne Kaldenbach, Karin E de Visser
hMRP8-ATTAC Mice: A New Model for Conditional and Reversible Neutrophil Ablation. Cells 11 (15) (2022)
Claudia Burrello, Karin E de Visser
Pulling the Strings of the Tumor Microenvironment. Cancer immunology research 10 (1) (2021)
Stefan Prekovic, Karianne Schuurman, Isabel Mayayo-Peralta, Anna G Manjón, Mark Buijs, Selçuk Yavuz, Max D Wellenstein, Alejandro Barrera, Kim Monkhorst, Anne Huber, Ben Morris, Cor Lieftink, Theofilos Chalkiadakis, Ferhat Alkan, Joana Silva, Balázs Győrffy, Liesbeth Hoekman, Bram van den Broek, Hans Teunissen, Donna O Debets, Tesa Severson, Jos Jonkers, Timothy E Reddy, Karin E de Visser, William James Faller, Roderick L Beijersbergen, Maarten Altelaar, Elzo de Wit, Rene Medema, Wilbert Zwart
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nature communications 12 (1) (2021)
Anni Laine, Srikar G Nagelli, Caroline C Farrington, Umar Butt, Anna N Cvrljevic, Julia P Vainonen, Femke M Feringa, Tove J Grönroos, Prson Gautam, Sofia Khan, Harri Jaakko Sihto, Xi Qiao, Karolina Pavic, Denise C Connolly, Pauliina Kronqvist, Laura L Elo, Jochen Maurer, Krister Wennerberg, Rene H Medema, Heikki Joensuu, Emilia Peuhu, Karin E de Visser, Goutham Narla, Jukka Westermarck
CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. Cancer research 81 (16) (2021)
Sjoerd Klarenbeek, Chris W Doornebal, Sjors M Kas, Nicola Bonzanni, Jinhyuk Bhin, Tanya M Braumuller, Ingrid van der Heijden, Mark Opdam, Philip C Schouten, Kelly Kersten, Roebi de Bruijn, Daniel Zingg, Julia Yemelyanenko, Lodewyk F A Wessels, Karin E de Visser, Jos Jonkers
Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system. Oncoimmunology 9 (1) (2020)
Hannah Garner, Karin E de Visser
Immune crosstalk in cancer progression and metastatic spread: a complex conversation. Nature reviews. Immunology 20 (8) (2020)
Camilla Salvagno, Metamia Ciampricotti, Sander Tuit, Cheei-Sing Hau, Antoinette van Weverwijk, Seth B Coffelt, Kelly Kersten, Kim Vrijland, Kevin Kos, Thomas Ulas, Ji-Ying Song, Chia-Huey Ooi, Dominik Rüttinger, Philippe A Cassier, Jos Jonkers, Joachim L Schultze, Carola H Ries, Karin E de Visser
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response. Nature cell biology 21 (4) (2019)
Leonie Voorwerk, Maarten Slagter, Hugo Mark Horlings, Karolina Sikorska, Koen K van de Vijver, Michiel de Maaker, Iris Nederlof, Roelof J C Kluin, Sarah Warren, SuFey Ong, Terry G Wiersma, Nicola S Russell, Ferry Lalezari, Philip C Schouten, Noor A M Bakker, Steven L C Ketelaars, Dennis Peters, Charlotte A H Lange, Erik D van Werkhoven, Harm van Tinteren, Ingrid A M Mandjes, Inge Kemper, Suzanne Onderwater, Myriam Chalabi, Sofie Wilgenhof, John B A G Haanen, Roberto Salgado, Karin E de Visser, Gabe S Sonke, Lodewyk F A Wessels, Sabine C Linn, Ton N M Schumacher, Christian U Blank, Marleen Kok
Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nature medicine 25 (6) (2019)
Marcelo Sobral-Leite, Koen K van de Vijver, Magali Michaut, Rianne van der Linden, Gerrit K J Hooijer, Hugo Mark Horlings, Tesa M Severson, Anna Marie Mulligan, Nayana Weerasooriya, Joyce Sanders, Annuska M Glas, Diederik Wehkamp, Lorenza Mittempergher, Kelly Kersten, Ashley Cimino-Mathews, Dennis Peters, Erik Hooijberg, Annegien Broeks, Marc J van de Vijver, René Bernards, Irene L Andrulis, Marleen Kok, Karin E de Visser, Marjanka K Schmidt
Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival. Oncoimmunology 7 (12) (2018)
Olga S Blomberg, Lorenzo Spagnuolo, Karin E de Visser
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities. Disease models & mechanisms 11 (10) (2018)